Answer
Tralokinumab improved eczema-related sleep problems at week 16 compared with placebo, as measured by Eczema-related sleep NRS, in ECZTRA 1 and ECZTRA 2 monotherapy trials and ECZTRA 3 with concomitant topical corticosteroids.
Sources for this answer
- Adtralza 150 mg solution for injection in pre-filled syringeLeo Laboratories Limited · emc · SmPC §5.1 Pharmacodynamic properties · Version 9Document updated
Sources checked